HECTOR J DIAZ RODRIGUEZ

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology SAN ANTONIO, TX NPI 1013221274

General Payments — all program years on this page

$4,580.68

Category: General Payments
Program years: PY2018–2024
Record count: 204
As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,191.42 across 51 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of payment	Amount	Records
Food and Beverage	$1,191.42	51

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entity	Amount	Records
Acerta Pharma LLC	$263.97	13
Aurinia Pharma U.S., Inc.	$173.20	6
NOVARTIS PHARMACEUTICALS CORPORATION	$115.94	4
Retrophin, Inc.	$108.17	5
Relypsa, Inc.	$89.55	4
Kyowa Kirin, Inc.	$54.02	2
Boehringer Ingelheim Pharmaceuticals, Inc.	$47.70	2
Xeris Pharmaceuticals, Inc.	$46.91	2
Amgen Inc.	$46.73	2
Otsuka America Pharmaceutical, Inc.	$46.40	2
CALLIDITAS THERAPEUTICS US INC.	$44.76	2
Ardelyx, Inc.	$40.40	2
Janssen Pharmaceuticals, Inc	$36.62	1
Fresenius USA Marketing, Inc.	$33.71	2
AKEBIA THERAPEUTICS INC	$27.24	1
OPKO Pharmaceuticals, LLC	$16.10	1

By program year

Program year	Amount	Records
2018	$215.66	7
2019	$227.27	7
2020	$117.33	6
2021	$355.84	14
2022	$785.98	40
2023	$1,687.18	79
2024	$1,191.42	51

Records — PY2024 (51)

Record ID	Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Source
1078213821	Janssen Pharmaceuticals, Inc	$36.62	03/01/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1086918245	Novartis Pharmaceuticals Corporation	$32.89	01/17/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1086918251	Novartis Pharmaceuticals Corporation	$25.70	05/15/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1086918255	Novartis Pharmaceuticals Corporation	$28.04	08/21/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1086918257	Novartis Pharmaceuticals Corporation	$29.31	09/30/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104203239	AstraZeneca Pharmaceuticals LP	$21.81	07/10/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104342496	AstraZeneca Pharmaceuticals LP	$24.01	08/14/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104367925	AstraZeneca Pharmaceuticals LP	$18.64	09/09/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104430115	AstraZeneca Pharmaceuticals LP	$18.15	04/15/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104488484	AstraZeneca Pharmaceuticals LP	$20.62	01/22/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104547918	AstraZeneca Pharmaceuticals LP	$11.18	08/28/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104611040	AstraZeneca Pharmaceuticals LP	$26.23	12/11/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104652865	AstraZeneca Pharmaceuticals LP	$23.77	03/18/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104658371	AstraZeneca Pharmaceuticals LP	$19.94	03/12/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104747799	AstraZeneca Pharmaceuticals LP	$19.61	02/14/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1105543221	AstraZeneca Pharmaceuticals LP	$22.00	09/17/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1105669087	AstraZeneca Pharmaceuticals LP	$21.12	10/02/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1105736155	AstraZeneca Pharmaceuticals LP	$16.89	06/12/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1111563561	Amgen Inc.	$29.76	09/11/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1112844060	OPKO Pharmaceuticals, LLC	$16.10	08/26/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1117238983	Amgen Inc.	$16.97	03/07/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1117835994	Boehringer Ingelheim Pharmaceuticals, Inc.	$22.23	01/30/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1117835996	Boehringer Ingelheim Pharmaceuticals, Inc.	$25.47	02/02/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118885175	Otsuka America Pharmaceutical, Inc.	$24.32	02/15/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118885177	Otsuka America Pharmaceutical, Inc.	$22.08	07/13/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1124036315	Vifor Pharma, Inc.	$23.89	05/06/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1124037238	Vifor Pharma, Inc.	$21.03	03/05/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1124040771	Vifor Pharma, Inc.	$25.76	01/11/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1124061160	Vifor Pharma, Inc.	$18.87	09/24/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1127031145	Kyowa Kirin, Inc.	$29.10	06/10/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1127031147	Kyowa Kirin, Inc.	$24.92	08/19/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1141511599	CALLIDITAS THERAPEUTICS US INC.	$21.94	03/19/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1141522379	CALLIDITAS THERAPEUTICS US INC.	$22.82	09/18/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1144596310	Xeris Pharmaceuticals, Inc.	$22.53	07/22/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1144596312	Xeris Pharmaceuticals, Inc.	$24.38	08/06/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1145830031	AKEBIA THERAPEUTICS INC	$27.24	11/04/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1146678297	Ardelyx, Inc.	$20.47	01/23/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1146678299	Ardelyx, Inc.	$19.93	08/28/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1149943391	Travere Therapeutics, Inc.	$17.88	01/18/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1149943395	Travere Therapeutics, Inc.	$20.54	11/21/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1149943399	Travere Therapeutics, Inc.	$20.95	06/04/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1149943403	Travere Therapeutics, Inc.	$21.96	09/25/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1149943407	Travere Therapeutics, Inc.	$26.84	08/12/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1150679185	Aurinia Pharma U.S., Inc.	$29.12	02/21/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1150679187	Aurinia Pharma U.S., Inc.	$29.47	03/20/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1150679189	Aurinia Pharma U.S., Inc.	$29.23	04/15/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1150679191	Aurinia Pharma U.S., Inc.	$27.37	05/22/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1150679193	Aurinia Pharma U.S., Inc.	$29.34	07/08/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1150679195	Aurinia Pharma U.S., Inc.	$28.67	08/05/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1154193748	Fresenius USA Marketing, Inc.	$14.71	07/01/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1154193750	Fresenius USA Marketing, Inc.	$19.00	01/25/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS

Provenance & corrections

Dataset: CMS Open Payments — General Payments
Source: CMS Open Payments dataset (bulk file)
Publisher of source data: Centers for Medicare & Medicaid Services
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.